Paxlovid 150 mg + 100 mg film-coated tablets
Sponsors
Inserm, Atea Pharmaceuticals Inc., Atea Pharmaceuticals Inc., Stichting Amsterdam UMC, Region Vaesterbotten, Umea University
Conditions
COVID-19COVID-19 and Severely Impaired B-cell FunctionCovid-19SARS-CoV-2 infection
Phase 2
OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV Study
RecruitingCTIS2022-501408-81-01
Start: 2024-03-04Target: 304Updated: 2025-12-19
Randomized Open Label Trial Evaluating Efficacy and Safety of Intravenous Immunoglobulin (IVIg, Privigen) as Add-on to SoC Versus SoC Alone for Coronavirus Disease 2019 (COVID-19) in Patients with Severely Impaired B-cell Function
Not yet recruitingCTIS2025-522756-97-00
Target: 92Updated: 2026-02-06